BioCentury | Nov 2, 2019
Company News

Management tracks: Genmab, Kintai, Aerie, Oasmia, Sangamo, Ovid, Checkmate, Third Pole, Actimed, IMV, Entasis, Rafael, Evaxion and Arvelle

...Chaudhary as CBO. Chaudhary was head of business development and licensing at Biogen Inc. (NASDAQ:BIIB). Third Pole Therapeutics Inc....
...Therapeutics Inc. Aerie Pharmaceuticals Inc. Oasmia Pharmaceutical AB Rafael Pharmaceuticals Inc. Arvelle Therapeutics GmbH Ovid Therapeutics Inc. Checkmate Pharmaceuticals Inc. Entasis Therapeutics Inc. Third Pole Therapeutics Inc....
Items per page:
1 - 1 of 1
BioCentury | Nov 2, 2019
Company News

Management tracks: Genmab, Kintai, Aerie, Oasmia, Sangamo, Ovid, Checkmate, Third Pole, Actimed, IMV, Entasis, Rafael, Evaxion and Arvelle

...Chaudhary as CBO. Chaudhary was head of business development and licensing at Biogen Inc. (NASDAQ:BIIB). Third Pole Therapeutics Inc....
...Therapeutics Inc. Aerie Pharmaceuticals Inc. Oasmia Pharmaceutical AB Rafael Pharmaceuticals Inc. Arvelle Therapeutics GmbH Ovid Therapeutics Inc. Checkmate Pharmaceuticals Inc. Entasis Therapeutics Inc. Third Pole Therapeutics Inc....
Items per page:
1 - 1 of 1